Insight into the selective mechanism of phosphoinositide 3‐kinase γ with benzothiazole and thiazolopiperidine γ‐specific inhibitors by in silico approaches

The phosphoinositide 3‐kinase γ (PI3Kγ) has been verified to be a potential drug target for the treatments of various human physical disorders. Although received lots of attention, the development of PI3Kγ‐selective inhibitors is still a challenging subject because of its unique protein structural f...

Full description

Saved in:
Bibliographic Details
Published inChemical biology & drug design Vol. 93; no. 5; pp. 818 - 831
Main Authors Zhu, Jingyu, Li, Kan, Xu, Lei, Jin, Jian
Format Journal Article
LanguageEnglish
Published England 01.05.2019
Subjects
Online AccessGet full text
ISSN1747-0277
1747-0285
1747-0285
DOI10.1111/cbdd.13469

Cover

Loading…
Abstract The phosphoinositide 3‐kinase γ (PI3Kγ) has been verified to be a potential drug target for the treatments of various human physical disorders. Although received lots of attention, the development of PI3Kγ‐selective inhibitors is still a challenging subject because of its unique protein structural features. Aiming to uncover the interaction mechanism between the selective inhibitors and PI3Kγ, a series of benzothiazole and thiazolopiperidine PI3Kγ isoform‐selective inhibitors were studied with an integrated in silico strategy by combining molecular docking, molecular dynamic simulations, binding free energy calculations, and decomposition analysis. Firstly, three molecular docking models, including rigid receptor docking, induced fit docking (IFD), and quantum mechanical‐polarized ligand docking, were respectively, built, and the IFD preliminarily predicted the docking poses of all studied inhibitors and roughly analyzed the binding mechanism. Secondly, four binding complexes with representative inhibitors were selected to perform molecular dynamic simulations and free energy calculations. The predicted binding energies were consistent with the experimental bioactivities and different binding patterns between potent and weak inhibitors were uncovered. Finally, through the Molecular Mechanics/Generalized Born Surface Area binding free energy decomposition, residue–inhibitor interactions spectra were obtained and several key residues contributing to favorable binding were highlighted, which provides valuable information for rational PI3Kγ inhibitor design and modification. A computational strategy, which combines molecular docking, molecular dynamics simulations, free energy calculations, was employed to explore the binding mechanisms of γ‐selective inhibitors to phosphoinositide 3‐kinases γ (PI3Kγ). Several key residues contributing to PI3Kγ‐specific binding were highlighted, which provides valuable information for rational PI3Kγ‐selective inhibitor design.
AbstractList The phosphoinositide 3‐kinase γ ( PI 3Kγ) has been verified to be a potential drug target for the treatments of various human physical disorders. Although received lots of attention, the development of PI 3Kγ‐selective inhibitors is still a challenging subject because of its unique protein structural features. Aiming to uncover the interaction mechanism between the selective inhibitors and PI 3Kγ, a series of benzothiazole and thiazolopiperidine PI 3Kγ isoform‐selective inhibitors were studied with an integrated in silico strategy by combining molecular docking, molecular dynamic simulations, binding free energy calculations, and decomposition analysis. Firstly, three molecular docking models, including rigid receptor docking, induced fit docking ( IFD ), and quantum mechanical‐polarized ligand docking, were respectively, built, and the IFD preliminarily predicted the docking poses of all studied inhibitors and roughly analyzed the binding mechanism. Secondly, four binding complexes with representative inhibitors were selected to perform molecular dynamic simulations and free energy calculations. The predicted binding energies were consistent with the experimental bioactivities and different binding patterns between potent and weak inhibitors were uncovered. Finally, through the Molecular Mechanics/Generalized Born Surface Area binding free energy decomposition, residue–inhibitor interactions spectra were obtained and several key residues contributing to favorable binding were highlighted, which provides valuable information for rational PI 3Kγ inhibitor design and modification.
The phosphoinositide 3‐kinase γ (PI3Kγ) has been verified to be a potential drug target for the treatments of various human physical disorders. Although received lots of attention, the development of PI3Kγ‐selective inhibitors is still a challenging subject because of its unique protein structural features. Aiming to uncover the interaction mechanism between the selective inhibitors and PI3Kγ, a series of benzothiazole and thiazolopiperidine PI3Kγ isoform‐selective inhibitors were studied with an integrated in silico strategy by combining molecular docking, molecular dynamic simulations, binding free energy calculations, and decomposition analysis. Firstly, three molecular docking models, including rigid receptor docking, induced fit docking (IFD), and quantum mechanical‐polarized ligand docking, were respectively, built, and the IFD preliminarily predicted the docking poses of all studied inhibitors and roughly analyzed the binding mechanism. Secondly, four binding complexes with representative inhibitors were selected to perform molecular dynamic simulations and free energy calculations. The predicted binding energies were consistent with the experimental bioactivities and different binding patterns between potent and weak inhibitors were uncovered. Finally, through the Molecular Mechanics/Generalized Born Surface Area binding free energy decomposition, residue–inhibitor interactions spectra were obtained and several key residues contributing to favorable binding were highlighted, which provides valuable information for rational PI3Kγ inhibitor design and modification. A computational strategy, which combines molecular docking, molecular dynamics simulations, free energy calculations, was employed to explore the binding mechanisms of γ‐selective inhibitors to phosphoinositide 3‐kinases γ (PI3Kγ). Several key residues contributing to PI3Kγ‐specific binding were highlighted, which provides valuable information for rational PI3Kγ‐selective inhibitor design.
The phosphoinositide 3-kinase γ (PI3Kγ) has been verified to be a potential drug target for the treatments of various human physical disorders. Although received lots of attention, the development of PI3Kγ-selective inhibitors is still a challenging subject because of its unique protein structural features. Aiming to uncover the interaction mechanism between the selective inhibitors and PI3Kγ, a series of benzothiazole and thiazolopiperidine PI3Kγ isoform-selective inhibitors were studied with an integrated in silico strategy by combining molecular docking, molecular dynamic simulations, binding free energy calculations, and decomposition analysis. Firstly, three molecular docking models, including rigid receptor docking, induced fit docking (IFD), and quantum mechanical-polarized ligand docking, were respectively, built, and the IFD preliminarily predicted the docking poses of all studied inhibitors and roughly analyzed the binding mechanism. Secondly, four binding complexes with representative inhibitors were selected to perform molecular dynamic simulations and free energy calculations. The predicted binding energies were consistent with the experimental bioactivities and different binding patterns between potent and weak inhibitors were uncovered. Finally, through the Molecular Mechanics/Generalized Born Surface Area binding free energy decomposition, residue-inhibitor interactions spectra were obtained and several key residues contributing to favorable binding were highlighted, which provides valuable information for rational PI3Kγ inhibitor design and modification.
The phosphoinositide 3-kinase γ (PI3Kγ) has been verified to be a potential drug target for the treatments of various human physical disorders. Although received lots of attention, the development of PI3Kγ-selective inhibitors is still a challenging subject because of its unique protein structural features. Aiming to uncover the interaction mechanism between the selective inhibitors and PI3Kγ, a series of benzothiazole and thiazolopiperidine PI3Kγ isoform-selective inhibitors were studied with an integrated in silico strategy by combining molecular docking, molecular dynamic simulations, binding free energy calculations, and decomposition analysis. Firstly, three molecular docking models, including rigid receptor docking, induced fit docking (IFD), and quantum mechanical-polarized ligand docking, were respectively, built, and the IFD preliminarily predicted the docking poses of all studied inhibitors and roughly analyzed the binding mechanism. Secondly, four binding complexes with representative inhibitors were selected to perform molecular dynamic simulations and free energy calculations. The predicted binding energies were consistent with the experimental bioactivities and different binding patterns between potent and weak inhibitors were uncovered. Finally, through the Molecular Mechanics/Generalized Born Surface Area binding free energy decomposition, residue-inhibitor interactions spectra were obtained and several key residues contributing to favorable binding were highlighted, which provides valuable information for rational PI3Kγ inhibitor design and modification.The phosphoinositide 3-kinase γ (PI3Kγ) has been verified to be a potential drug target for the treatments of various human physical disorders. Although received lots of attention, the development of PI3Kγ-selective inhibitors is still a challenging subject because of its unique protein structural features. Aiming to uncover the interaction mechanism between the selective inhibitors and PI3Kγ, a series of benzothiazole and thiazolopiperidine PI3Kγ isoform-selective inhibitors were studied with an integrated in silico strategy by combining molecular docking, molecular dynamic simulations, binding free energy calculations, and decomposition analysis. Firstly, three molecular docking models, including rigid receptor docking, induced fit docking (IFD), and quantum mechanical-polarized ligand docking, were respectively, built, and the IFD preliminarily predicted the docking poses of all studied inhibitors and roughly analyzed the binding mechanism. Secondly, four binding complexes with representative inhibitors were selected to perform molecular dynamic simulations and free energy calculations. The predicted binding energies were consistent with the experimental bioactivities and different binding patterns between potent and weak inhibitors were uncovered. Finally, through the Molecular Mechanics/Generalized Born Surface Area binding free energy decomposition, residue-inhibitor interactions spectra were obtained and several key residues contributing to favorable binding were highlighted, which provides valuable information for rational PI3Kγ inhibitor design and modification.
Author Xu, Lei
Jin, Jian
Li, Kan
Zhu, Jingyu
Author_xml – sequence: 1
  givenname: Jingyu
  orcidid: 0000-0002-9553-1765
  surname: Zhu
  fullname: Zhu, Jingyu
  email: jingyuzhu@jiangnan.edu.cn
  organization: Jiangnan University
– sequence: 2
  givenname: Kan
  surname: Li
  fullname: Li, Kan
  organization: Jiangnan University
– sequence: 3
  givenname: Lei
  orcidid: 0000-0002-4095-6539
  surname: Xu
  fullname: Xu, Lei
  organization: Jiangsu University of Technology
– sequence: 4
  givenname: Jian
  surname: Jin
  fullname: Jin, Jian
  email: jianjin@jiangnan.edu.cn
  organization: Jiangnan University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/30582283$$D View this record in MEDLINE/PubMed
BookMark eNp9kUuO1DAQhi00iHnAhgMgLxFSD7bjOMkSeniMNBIbWEdOuUwKEjvEbkY9K47AFTgD9-AQnIQ03cwCIUoqVZX0_VVS_afsKMSAjD2U4lwu8RQ6585loU1zh53ISlcroery6LavqmN2mtIHIbQuVX2PHReirJWqixP27TIket9nTiFHnnvkCQeETJ-Rjwi9DZRGHj2f-piWpBATZXLIi59fvn6kYBPyH9_5NeWedxhuYu7J3sQBuQ2OH4Y40YQzOQo7eBGmCYE8wXK2p45ynBPvtsvEEw0EkdtpmqOFHtN9dtfbIeGDQz1j716-eLt-vbp68-py_exqBYVqmpVTugJjOmOMVKU3lVYGFRSmAm9BddYKpxoNZS3BiEI5b6DxUlsFoGovizP2eL93Ofxpgym3IyXAYbAB4ya1Shohdd0osaCPDuimG9G100yjnbftn7cuwJM9AHNMaUZ_i0jR7jxrd561vz1bYPEXDJRtphjybGn4t0TuJdc04PY_y9v184uLveYXKVKwJg
CitedBy_id crossref_primary_10_1016_j_compbiolchem_2021_107517
crossref_primary_10_1111_cbdd_13991
crossref_primary_10_1039_C9RA02649E
crossref_primary_10_1002_adts_202400312
crossref_primary_10_1007_s11224_020_01643_4
crossref_primary_10_1002_adts_202200835
crossref_primary_10_1002_cbdv_201900105
crossref_primary_10_1002_med_21770
crossref_primary_10_1080_13543776_2021_1854729
crossref_primary_10_3389_fmolb_2020_00083
crossref_primary_10_1016_j_compbiomed_2022_105642
crossref_primary_10_1111_cbdd_13838
crossref_primary_10_1007_s11030_024_10918_5
crossref_primary_10_1007_s11030_021_10243_1
crossref_primary_10_1016_j_ejmech_2022_114824
Cites_doi 10.1182/blood-2005-03-0944
10.1002/jcc.10349
10.1021/j100142a004
10.1021/jm051256o
10.1021/jm500362j
10.1002/chin.200318218
10.1021/mp100041b
10.1007/s10822-007-9133-z
10.1021/jp003919d
10.1002/(SICI)1096-987X(19990130)20:2<217::AID-JCC4>3.0.CO;2-A
10.1016/j.bmcl.2006.10.080
10.1038/nrm2882
10.1039/c2mb25114k
10.1021/acs.jctc.5b00864
10.1042/BST0340647
10.1093/carcin/22.11.1831
10.1002/jcc.21366
10.1063/1.464397
10.1021/acs.jmedchem.5b00498
10.1182/blood-2010-03-275305
10.1021/ci200159g
10.1039/C6CP03670H
10.1038/nrd2145
10.1039/C4CP01388C
10.1016/0021-9991(77)90098-5
10.1021/jm0306430
10.1016/j.drudis.2015.03.009
10.1039/c2mb25157d
10.1126/science.296.5573.1655
10.1002/jcc.20290
10.1039/C4CP03179B
10.1021/jp404160y
10.1063/1.445869
10.1093/bioinformatics/btr294
10.1016/S0005-2760(98)00139-8
10.1021/acscentsci.7b00419
10.1002/jcc.20145
10.1038/nri2036
10.1111/cbdd.12907
10.1016/S0022-2836(03)00610-7
10.1038/nri1056
10.1073/pnas.0907304107
10.1016/j.jmb.2007.12.054
10.1002/jcc.20222
10.1006/jmbi.2000.4057
10.1039/c2mb25146a
10.1039/C6CP01555G
10.1038/nchembio.957
10.2174/0929867321666140601204513
10.1039/C7CP07623A
10.1261/rna.065896.118
10.1021/ci300541c
10.1021/jp994072s
10.4049/jimmunol.1103173
10.1039/c2mb25217a
10.1080/07391102.2016.1199328
10.1021/ci400188q
ContentType Journal Article
Copyright 2018 John Wiley & Sons A/S
2018 John Wiley & Sons A/S.
Copyright_xml – notice: 2018 John Wiley & Sons A/S
– notice: 2018 John Wiley & Sons A/S.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1111/cbdd.13469
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList CrossRef

MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Chemistry
EISSN 1747-0285
EndPage 831
ExternalDocumentID 30582283
10_1111_cbdd_13469
CBDD13469
Genre article
Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: Fundamental Research Funds for the Central Universities
  funderid: JUSRP11892
– fundername: National Natural Science Foundation of China
  funderid: 21807049
GroupedDBID ---
.3N
.GA
.GJ
.Y3
05W
0R~
10A
1OC
29B
31~
33P
36B
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5HH
5LA
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AAHQN
AAIPD
AAMNL
AANHP
AANLZ
AAONW
AASGY
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABDBF
ABEML
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGOF
ACMXC
ACPOU
ACRPL
ACSCC
ACUHS
ACXBN
ACXQS
ACYXJ
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADXAS
ADZMN
ADZOD
AEEZP
AEGXH
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFPM
AFGKR
AFPWT
AFWVQ
AFZJQ
AHBTC
AIACR
AITYG
AIURR
AIWBW
AJBDE
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
EAD
EAP
EAS
EBC
EBD
EBS
EJD
EMB
EMK
EMOBN
EPT
EST
ESX
EX3
F00
F01
F04
F5P
FEDTE
FUBAC
G-S
G.N
GODZA
HF~
HGLYW
HVGLF
HZI
IHE
IX1
KBYEO
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK0
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N9A
NDZJH
O66
OIG
OVD
P2W
P4B
P4D
Q.N
Q11
QB0
Q~Q
R.K
RJQFR
ROL
RX1
SUPJJ
SV3
TEORI
TUS
UB1
V8K
W8V
W99
WBKPD
WIH
WIJ
WIK
WNSPC
WOHZO
WOW
WQJ
WRC
WXI
WXSBR
WYISQ
XG1
~IA
~KM
~WT
AAYXX
AGHNM
AGQPQ
AGYGG
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
ID FETCH-LOGICAL-c3299-d247c66b666125f67426e2c367cfac2baa0d294c581c6032df6c9f14a2cc28f13
IEDL.DBID DR2
ISSN 1747-0277
1747-0285
IngestDate Fri Jul 11 14:33:42 EDT 2025
Thu Apr 03 07:11:01 EDT 2025
Thu Apr 24 22:57:09 EDT 2025
Tue Jul 01 04:25:21 EDT 2025
Wed Jan 22 17:00:22 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 5
Keywords selective inhibitor
molecular docking
PI3Kγ
molecular dynamic simulation
MM-GBSA
Language English
License 2018 John Wiley & Sons A/S.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3299-d247c66b666125f67426e2c367cfac2baa0d294c581c6032df6c9f14a2cc28f13
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0002-9553-1765
0000-0002-4095-6539
PMID 30582283
PQID 2160148920
PQPubID 23479
PageCount 14
ParticipantIDs proquest_miscellaneous_2160148920
pubmed_primary_30582283
crossref_primary_10_1111_cbdd_13469
crossref_citationtrail_10_1111_cbdd_13469
wiley_primary_10_1111_cbdd_13469_CBDD13469
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate May 2019
2019-05-00
20190501
PublicationDateYYYYMMDD 2019-05-01
PublicationDate_xml – month: 05
  year: 2019
  text: May 2019
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Chemical biology & drug design
PublicationTitleAlternate Chem Biol Drug Des
PublicationYear 2019
References 2010; 11
2017; 3
2011; 117
2006; 34
2010; 107
2017; 89
1977; 23
2005; 26
2014; 21
2001; 105
2017; 35
2000; 96
2013; 53
2005; 106
2013; 117
2014; 16
2003; 3
2007; 7
2011; 27
2007; 21
2010; 7
2007; 17
1998; 1436
2015; 58
2010; 31
2012; 189
2002; 296
2004; 47
2006; 5
2011a; 51
1999; 20
2004
2006; 2
2016; 18
2001; 22
2018; 20
2003; 330
2016; 12
2018; 24
2003; 34
2000; 104
2000; 303
2000; 106
2006; 49
2015; 20
1993; 98
2011b; 32
1993; 97
2011; 51
2003; 24
2008; 376
2012; 8
1998; 79
e_1_2_7_5_1
e_1_2_7_3_1
e_1_2_7_9_1
e_1_2_7_7_1
e_1_2_7_19_1
e_1_2_7_60_1
e_1_2_7_17_1
e_1_2_7_62_1
e_1_2_7_15_1
e_1_2_7_64_1
e_1_2_7_13_1
e_1_2_7_43_1
e_1_2_7_11_1
e_1_2_7_45_1
e_1_2_7_47_1
e_1_2_7_49_1
e_1_2_7_28_1
Berman H. M. (e_1_2_7_4_1) 2000; 106
Hou T. (e_1_2_7_26_1) 2011; 32
Hou T. (e_1_2_7_25_1) 2011; 51
e_1_2_7_50_1
e_1_2_7_31_1
e_1_2_7_52_1
e_1_2_7_23_1
e_1_2_7_33_1
e_1_2_7_54_1
e_1_2_7_21_1
e_1_2_7_35_1
e_1_2_7_56_1
e_1_2_7_37_1
Sasaki O. (e_1_2_7_41_1) 2000; 96
e_1_2_7_58_1
e_1_2_7_39_1
Xu X. (e_1_2_7_53_1) 2006; 2
e_1_2_7_6_1
e_1_2_7_8_1
e_1_2_7_18_1
e_1_2_7_16_1
e_1_2_7_40_1
e_1_2_7_61_1
e_1_2_7_2_1
e_1_2_7_14_1
e_1_2_7_42_1
e_1_2_7_63_1
e_1_2_7_12_1
e_1_2_7_44_1
e_1_2_7_10_1
e_1_2_7_46_1
e_1_2_7_48_1
e_1_2_7_27_1
e_1_2_7_29_1
e_1_2_7_51_1
e_1_2_7_30_1
e_1_2_7_24_1
e_1_2_7_32_1
e_1_2_7_55_1
e_1_2_7_22_1
e_1_2_7_34_1
e_1_2_7_57_1
e_1_2_7_20_1
e_1_2_7_36_1
e_1_2_7_59_1
e_1_2_7_38_1
References_xml – volume: 49
  start-page: 6177
  year: 2006
  article-title: Extra precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein−ligand complexes
  publication-title: Journal of Medicinal Chemistry
– volume: 53
  start-page: 2376
  year: 2013
  end-page: 2389
  article-title: Insight into crizotinib resistance mechanisms caused by three mutations in ALK tyrosine kinase using free energy calculation approaches
  publication-title: Journal of Chemical Information and Modeling
– volume: 12
  start-page: 281
  year: 2016
  end-page: 296
  article-title: OPLS3: A force field providing broad coverage of drug‐like small molecules and proteins
  publication-title: Journal of Chemical Theory and Computation
– volume: 376
  start-page: 1201
  year: 2008
  end-page: 1214
  article-title: Characterization of domain‐peptide interaction interface: A case study on the amphiphysin‐1 SH3 domain
  publication-title: Journal of Molecular Biology
– volume: 53
  start-page: 210
  year: 2013
  end-page: 222
  article-title: Exploring the molecular mechanism of cross‐resistance to HIV‐1 integrase strand transfer inhibitors by molecular dynamics simulation and residue interaction network analysis
  publication-title: Journal of Chemical Information and Modeling
– volume: 330
  start-page: 891
  year: 2003
  end-page: 913
  article-title: Insights into protein‐protein binding by binding free energy calculation and free energy decomposition for the Ras‐Raf and Ras‐RalGDS complexes
  publication-title: Journal of Molecular Biology
– volume: 20
  start-page: 14450
  year: 2018
  end-page: 14460
  article-title: Assessing the performance of MM/PBSA and MM/GBSA methods. 7. Entropy effects on the performance of end‐point binding free energy calculation approaches
  publication-title: Physical Chemistry Chemical Physics
– volume: 7
  start-page: 191
  year: 2007
  end-page: 201
  article-title: PI3K delta and PI3K gamma: Partners in crime in inflammation in rheumatoid arthritis and beyond?
  publication-title: Nature Reviews Immunology
– volume: 58
  start-page: 517
  year: 2015
  end-page: 521
  article-title: Structural basis for isoform selectivity in a class of benzothiazole inhibitors of phosphoinositide 3‐kinase gamma
  publication-title: Journal of Medicinal Chemistry
– volume: 51
  start-page: 69
  year: 2011a
  end-page: 82
  article-title: Hou T, Wang J, Li Y, Wang W. Assessing the performance of the MM/PBSA and MM/GBSA methods. 1. The accuracy of binding free energy calculations based on molecular dynamics simulations.
  publication-title: Journal of Computational Chemistry
– volume: 5
  start-page: 903
  year: 2006
  end-page: 918
  article-title: PI3Kgamma inhibition: Towards an ‘aspirin of the 21st century’?
  publication-title: Nature Reviews Drug Discovery
– volume: 17
  start-page: 756
  year: 2007
  end-page: 760
  article-title: Design and synthesis of phenethyl benzo[1,4]oxazine‐3‐ones as potent inhibitors of PI3Kinase gamma
  publication-title: Bioorganic and Medicinal Chemistry Letters
– volume: 26
  start-page: 915
  year: 2005
  article-title: Importance of accurate charges in molecular docking: Quantum mechanical/molecular mechanical (QM/MM) approach
  publication-title: Journal of Computational Chemistry
– volume: 189
  start-page: 4612
  year: 2012
  end-page: 4620
  article-title: Blockade of phosphatidylinositol 3‐kinase (PI3K)delta or PI3K gamma reduces IL‐17 and ameliorates imiquimod‐induced psoriasis‐like dermatitis
  publication-title: Journal of Immunology
– volume: 34
  start-page: 647
  year: 2006
  end-page: 662
  article-title: Signalling through class I PI3Ks in mammalian cells
  publication-title: Biochemical Society Transactions
– volume: 18
  start-page: 12964
  year: 2016
  article-title: Comprehensive evaluation of ten docking programs on a diverse set of protein‐ligand complexes: The prediction accuracy of sampling power and scoring power
  publication-title: Physical Chemistry Chemical Physics
– volume: 20
  start-page: 217
  year: 1999
  end-page: 230
  article-title: Approximate atomic surfaces from linear combinations of pairwise overlaps (LCPO)
  publication-title: Journal of Computational Chemistry
– volume: 26
  start-page: 1668
  year: 2005
  end-page: 1688
  article-title: The Amber biomolecular simulation programs
  publication-title: Journal of Computational Chemistry
– volume: 21
  start-page: 3173
  year: 2014
  end-page: 3187
  article-title: Targeting the phosphatidylinositol 3‐kinase/AKT pathway for the treatment of multiple myeloma
  publication-title: Current Medicinal Chemistry
– volume: 18
  start-page: 22129
  year: 2016
  end-page: 22139
  article-title: Assessing the performance of the MM/PBSA and MM/GBSA methods. 6. Capability to predict protein‐protein binding free energies and re‐rank binding poses generated by protein‐protein docking
  publication-title: Physical Chemistry Chemical Physics
– volume: 11
  start-page: 329
  year: 2010
  end-page: 341
  article-title: The emerging mechanisms of isoform‐specific PI3K signalling
  publication-title: Nature Reviews Molecular Cell Biology
– volume: 1436
  start-page: 127
  year: 1998
  end-page: 150
  article-title: Structure and function of phosphoinositide 3‐kinases
  publication-title: Biochimica et Biophysica Acta ‐ Molecular and Cell Biology of Lipids
– volume: 106
  start-page: 1432
  year: 2005
  end-page: 1440
  article-title: Sequential activation of class IB and class IA PI3K is important for the primed respiratory burst of human but not murine neutrophils
  publication-title: Blood
– volume: 23
  start-page: 327
  year: 1977
  end-page: 341
  article-title: Numerical integration of the cartesian equations of motion of a system with constraints: Molecular dynamics of n ‐alkanes
  publication-title: Journal of Computational Physics
– volume: 35
  start-page: 1899
  year: 2017
  end-page: 1915
  article-title: Virtual screening of small molecules databases for discovery of novel PARP‐1 inhibitors: Combination of in silico and in vitro studies
  publication-title: Journal of Biomolecular Structure and Dynamics
– volume: 2
  start-page: 95
  year: 2006
  end-page: 103
  article-title: Recent advances in free energy calculations with a combination of molecular mechanics and continuum models
  publication-title: Current Computer‐Aided Drug Design
– volume: 3
  start-page: 1208
  year: 2017
  end-page: 1220
  article-title: Combating drug‐resistant mutants of anaplastic lymphoma kinase with potent and selective type‐I (1/2) inhibitors by stabilizing unique DFG‐shifted loop conformation
  publication-title: ACS Central Science
– year: 2004
– volume: 32
  start-page: 866
  year: 2011b
  end-page: 877
  article-title: Assessing the performance of the molecular mechanics/Poisson Boltzmann surface area and molecular mechanics/generalized Born surface area methods. II. The accuracy of ranking poses generated from docking
  publication-title: Journal of Chemical Information and Modeling
– volume: 3
  start-page: 317
  year: 2003
  end-page: 330
  article-title: PI3K in lymphocyte development, differentiation and activation
  publication-title: Nature Reviews Immunology
– volume: 26
  start-page: 114
  year: 2005
  article-title: Junmei Wang, Romain M. Wolf, James W. Caldwell, Peter A. Kollman, and David A. Case, “Development and testing of a general amber force field” Journal of Computational Chemistry(2004) 25(9) 1157–1174
  publication-title: Journal of Computational Chemistry
– volume: 105
  start-page: 6474
  year: 2001
  end-page: 6487
  article-title: Evaluation and reparametrization of the OPLS‐AA force field for proteins via comparison with accurate quantum chemical calculations on peptides
  publication-title: Journal of Physical Chemistry B
– volume: 117
  start-page: 8408
  year: 2013
  end-page: 8421
  article-title: Assessing the performance of MM/PBSA and MM/GBSA methods. 3. The impact of force fields and ligand charge models
  publication-title: Journal of Physical Chemistry B
– volume: 97
  start-page: 10269
  year: 1993
  end-page: 10280
  article-title: A well‐behaved electrostatic potential based method using charge restraints for deriving atomic charges ‐ The Resp model
  publication-title: Journal of Physical Chemistry
– volume: 16
  start-page: 16719
  year: 2014
  end-page: 16729
  article-title: Assessing the performance of MM/PBSA and MM/GBSA methods. 4. Accuracies of MM/PBSA and MM/GBSA methodologies evaluated by various simulation protocols using PDBbind data set
  publication-title: Physical Chemistry Chemical Physics
– volume: 104
  start-page: 3712
  year: 2000
  end-page: 3720
  article-title: Modification of the generalized born model suitable for macromolecules
  publication-title: Journal of Physical Chemistry B
– volume: 106
  start-page: 149
  year: 2000
  end-page: 158
  article-title: The protein data bank
  publication-title: Genetica
– volume: 22
  start-page: 1831
  year: 2001
  end-page: 1835
  article-title: Anatomical site‐specific response to DNA damage is related to later tumor development in the rat azoxymethane colon carcinogenesis model
  publication-title: Carcinogenesis
– volume: 98
  start-page: 10089
  year: 1993
  end-page: 10092
  article-title: Particle mesh Ewald: An N·log(N) method for Ewald sums in large systems
  publication-title: Journal of Chemical Physics
– volume: 16
  start-page: 22035
  year: 2014
  end-page: 22045
  article-title: Assessing the performance of MM/PBSA and MM/GBSA methods. 5. Improved docking performance using high solute dielectric constant MM/GBSA and MM/PBSA rescoring
  publication-title: Physical Chemistry Chemical Physics
– volume: 303
  start-page: 567
  year: 2000
  end-page: 582
  article-title: Free energy calculations on dimer stability of the HIV protease using molecular dynamics and a continuum solvent model 1
  publication-title: Journal of Molecular Biology
– volume: 51
  start-page: 3235
  year: 2011
  article-title: Molecular dynamics simulation and free energy calculation studies of the binding mechanism of allosteric inhibitors with p38α MAP kinase
  publication-title: Journal of Chemical Information and Modeling
– volume: 117
  start-page: 591
  year: 2011
  end-page: 594
  article-title: CAL‐101, a p110delta selective phosphatidylinositol‐3‐kinase inhibitor for the treatment of B‐cell malignancies, inhibits PI3K signaling and cellular viability
  publication-title: Blood
– volume: 107
  start-page: 1321
  year: 2010
  end-page: 1326
  article-title: Detecting and understanding combinatorial mutation patterns responsible for HIV drug resistance
  publication-title: Proceedings of the National Academy of Sciences of the United States of America
– volume: 21
  start-page: 681
  year: 2007
  end-page: 691
  article-title: Epik: A software program for pK(a) prediction and protonation state generation for drug‐like molecules
  publication-title: Journal of Computer‐Aided Molecular Design
– volume: 27
  start-page: 1814
  year: 2011
  end-page: 1821
  article-title: Prediction of peptides binding to the PKA RIIalpha subunit using a hierarchical strategy
  publication-title: Bioinformatics
– volume: 58
  start-page: 5684
  year: 2015
  end-page: 5688
  article-title: Discovery of highly isoform selective thiazolopiperidine inhibitors of phosphoinositide 3‐kinase gamma
  publication-title: Journal of Medicinal Chemistry
– volume: 7
  start-page: 894
  year: 2010
  article-title: In silico identification of the potential drug resistance sites over 2009 influenza A (H1N1) virus neuraminidase
  publication-title: Molecular Pharmaceutics
– volume: 8
  start-page: 2135
  year: 2012
  end-page: 2144
  article-title: Understanding the effect of drug‐resistant mutations of HIV‐1 intasome on raltegravir action through molecular modeling study
  publication-title: Molecular BioSystems
– volume: 296
  start-page: 1655
  year: 2002
  end-page: 1657
  article-title: The phosphoinositide 3‐kinase pathway
  publication-title: Science
– volume: 8
  start-page: 2753
  year: 2012
  end-page: 2765
  article-title: Understanding the structural and energetic basis of inhibitor and substrate bound to the full‐length NS3/4A: Insights from molecular dynamics simulation, binding free energy calculation and network analysis
  publication-title: Molecular BioSystems
– volume: 24
  start-page: 1183
  year: 2018
  end-page: 1194
  article-title: Assessing the performance of MM/PBSA and MM/GBSA methods. 8. Predicting binding free energies and poses of protein‐RNA complexes
  publication-title: RNA (New York, NY)
– volume: 47
  start-page: 1739
  year: 2004
  end-page: 1749
  article-title: Glide: A new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy
  publication-title: Journal of Medicinal Chemistry
– volume: 20
  start-page: 988
  year: 2015
  end-page: 994
  article-title: Discovery of selective phosphatidylinositol 3‐kinase inhibitors to treat hematological malignancies
  publication-title: Drug Discovery Today
– volume: 34
  start-page: 273
  year: 2003
  end-page: 287
  article-title: Mapping the binding site of a large set of quinazoline type EGF‐R inhibitors using molecular field analyses and molecular docking studies
  publication-title: Cheminform
– volume: 89
  start-page: 846
  year: 2017
  end-page: 855
  article-title: Theoretical studies on the selective mechanisms of GSK3beta and CDK2 by molecular dynamics simulations and free energy calculations
  publication-title: Chemical Biology and Drug Design
– volume: 31
  start-page: 837
  year: 2010
  end-page: 846
  article-title: How to obtain statistically converged MM/GBSA results
  publication-title: Journal of Computational Chemistry
– volume: 24
  start-page: 1999
  year: 2003
  end-page: 2012
  article-title: A point‐charge force field for molecular mechanics simulations of proteins based on condensed‐phase quantum mechanical calculations
  publication-title: Journal of Computational Chemistry
– volume: 79
  start-page: 926
  year: 1998
  end-page: 935
  article-title: Comparison of simple potential functions for simulating liquid water
  publication-title: Journal of Chemical Physics
– volume: 96
  start-page: 704a
  year: 2000
  article-title: Frequent alteration in expression and structure of a candidate tumor suppressor, RIZ, in human leukemia
  publication-title: Blood
– volume: 8
  start-page: 2260
  year: 2012
  article-title: Understanding microscopic binding of macrophage migration inhibitory factor with phenolic hydrazones by molecular docking, molecular dynamics simulations and free energy calculations
  publication-title: Molecular BioSystems
– volume: 8
  start-page: 576
  year: 2012
  end-page: 582
  article-title: A selective inhibitor reveals PI3K gamma dependence of T(H)17 cell differentiation
  publication-title: Nature Chemical Biology
– volume: 8
  start-page: 3049
  year: 2012
  end-page: 3060
  article-title: Molecular dynamics and free energy studies on Aurora kinase A and its mutant bound with MLN8054: Insight into molecular mechanism of subtype selectivity
  publication-title: Molecular BioSystems
– ident: e_1_2_7_12_1
  doi: 10.1182/blood-2005-03-0944
– ident: e_1_2_7_14_1
  doi: 10.1002/jcc.10349
– ident: e_1_2_7_2_1
  doi: 10.1021/j100142a004
– ident: e_1_2_7_17_1
  doi: 10.1021/jm051256o
– ident: e_1_2_7_10_1
  doi: 10.1021/jm500362j
– ident: e_1_2_7_28_1
  doi: 10.1002/chin.200318218
– ident: e_1_2_7_33_1
  doi: 10.1021/mp100041b
– ident: e_1_2_7_42_1
  doi: 10.1007/s10822-007-9133-z
– ident: e_1_2_7_30_1
  doi: 10.1021/jp003919d
– ident: e_1_2_7_51_1
  doi: 10.1002/(SICI)1096-987X(19990130)20:2<217::AID-JCC4>3.0.CO;2-A
– ident: e_1_2_7_31_1
  doi: 10.1016/j.bmcl.2006.10.080
– ident: e_1_2_7_47_1
  doi: 10.1038/nrm2882
– ident: e_1_2_7_57_1
  doi: 10.1039/c2mb25114k
– volume: 51
  start-page: 69
  year: 2011
  ident: e_1_2_7_25_1
  article-title: Hou T, Wang J, Li Y, Wang W. Assessing the performance of the MM/PBSA and MM/GBSA methods. 1. The accuracy of binding free energy calculations based on molecular dynamics simulations.
  publication-title: Journal of Computational Chemistry
– ident: e_1_2_7_21_1
  doi: 10.1021/acs.jctc.5b00864
– ident: e_1_2_7_22_1
  doi: 10.1042/BST0340647
– ident: e_1_2_7_23_1
  doi: 10.1093/carcin/22.11.1831
– ident: e_1_2_7_19_1
  doi: 10.1002/jcc.21366
– ident: e_1_2_7_13_1
  doi: 10.1063/1.464397
– ident: e_1_2_7_11_1
  doi: 10.1021/acs.jmedchem.5b00498
– ident: e_1_2_7_32_1
  doi: 10.1182/blood-2010-03-275305
– ident: e_1_2_7_60_1
  doi: 10.1021/ci200159g
– ident: e_1_2_7_7_1
  doi: 10.1039/C6CP03670H
– ident: e_1_2_7_39_1
  doi: 10.1038/nrd2145
– ident: e_1_2_7_46_1
  doi: 10.1039/C4CP01388C
– ident: e_1_2_7_40_1
  doi: 10.1016/0021-9991(77)90098-5
– ident: e_1_2_7_16_1
  doi: 10.1021/jm0306430
– volume: 96
  start-page: 704a
  year: 2000
  ident: e_1_2_7_41_1
  article-title: Frequent alteration in expression and structure of a candidate tumor suppressor, RIZ, in human leukemia
  publication-title: Blood
– ident: e_1_2_7_63_1
  doi: 10.1016/j.drudis.2015.03.009
– ident: e_1_2_7_58_1
  doi: 10.1039/c2mb25157d
– ident: e_1_2_7_5_1
  doi: 10.1126/science.296.5573.1655
– ident: e_1_2_7_6_1
  doi: 10.1002/jcc.20290
– ident: e_1_2_7_45_1
  doi: 10.1039/C4CP03179B
– ident: e_1_2_7_55_1
  doi: 10.1021/jp404160y
– ident: e_1_2_7_29_1
  doi: 10.1063/1.445869
– ident: e_1_2_7_24_1
  doi: 10.1093/bioinformatics/btr294
– ident: e_1_2_7_52_1
  doi: 10.1016/S0005-2760(98)00139-8
– ident: e_1_2_7_36_1
  doi: 10.1021/acscentsci.7b00419
– ident: e_1_2_7_50_1
  doi: 10.1002/jcc.20145
– volume: 106
  start-page: 149
  year: 2000
  ident: e_1_2_7_4_1
  article-title: The protein data bank
  publication-title: Genetica
– ident: e_1_2_7_38_1
  doi: 10.1038/nri2036
– ident: e_1_2_7_62_1
  doi: 10.1111/cbdd.12907
– ident: e_1_2_7_20_1
  doi: 10.1016/S0022-2836(03)00610-7
– ident: e_1_2_7_34_1
  doi: 10.1038/nri1056
– ident: e_1_2_7_61_1
  doi: 10.1073/pnas.0907304107
– volume: 32
  start-page: 866
  year: 2011
  ident: e_1_2_7_26_1
  article-title: Assessing the performance of the molecular mechanics/Poisson Boltzmann surface area and molecular mechanics/generalized Born surface area methods. II. The accuracy of ranking poses generated from docking
  publication-title: Journal of Chemical Information and Modeling
– ident: e_1_2_7_27_1
  doi: 10.1016/j.jmb.2007.12.054
– ident: e_1_2_7_9_1
  doi: 10.1002/jcc.20222
– ident: e_1_2_7_48_1
  doi: 10.1006/jmbi.2000.4057
– ident: e_1_2_7_54_1
  doi: 10.1039/c2mb25146a
– ident: e_1_2_7_49_1
  doi: 10.1039/C6CP01555G
– ident: e_1_2_7_3_1
  doi: 10.1038/nchembio.957
– ident: e_1_2_7_64_1
  doi: 10.2174/0929867321666140601204513
– ident: e_1_2_7_18_1
– ident: e_1_2_7_43_1
  doi: 10.1039/C7CP07623A
– volume: 2
  start-page: 95
  year: 2006
  ident: e_1_2_7_53_1
  article-title: Recent advances in free energy calculations with a combination of molecular mechanics and continuum models
  publication-title: Current Computer‐Aided Drug Design
– ident: e_1_2_7_8_1
  doi: 10.1261/rna.065896.118
– ident: e_1_2_7_56_1
  doi: 10.1021/ci300541c
– ident: e_1_2_7_35_1
  doi: 10.1021/jp994072s
– ident: e_1_2_7_37_1
  doi: 10.4049/jimmunol.1103173
– ident: e_1_2_7_59_1
  doi: 10.1039/c2mb25217a
– ident: e_1_2_7_15_1
  doi: 10.1080/07391102.2016.1199328
– ident: e_1_2_7_44_1
  doi: 10.1021/ci400188q
SSID ssj0044528
Score 2.2985778
Snippet The phosphoinositide 3‐kinase γ (PI3Kγ) has been verified to be a potential drug target for the treatments of various human physical disorders. Although...
The phosphoinositide 3‐kinase γ ( PI 3Kγ) has been verified to be a potential drug target for the treatments of various human physical disorders. Although...
The phosphoinositide 3-kinase γ (PI3Kγ) has been verified to be a potential drug target for the treatments of various human physical disorders. Although...
SourceID proquest
pubmed
crossref
wiley
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 818
SubjectTerms Benzothiazoles - chemistry
Benzothiazoles - metabolism
Binding Sites
Catalytic Domain
Class Ib Phosphatidylinositol 3-Kinase - chemistry
Class Ib Phosphatidylinositol 3-Kinase - metabolism
Enzyme Inhibitors - chemistry
Enzyme Inhibitors - metabolism
Humans
Ligands
MM‐GBSA
molecular docking
Molecular Docking Simulation
molecular dynamic simulation
Molecular Dynamics Simulation
PI3Kγ
Piperidines - chemistry
Piperidines - metabolism
selective inhibitor
Thermodynamics
Title Insight into the selective mechanism of phosphoinositide 3‐kinase γ with benzothiazole and thiazolopiperidine γ‐specific inhibitors by in silico approaches
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fcbdd.13469
https://www.ncbi.nlm.nih.gov/pubmed/30582283
https://www.proquest.com/docview/2160148920
Volume 93
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NbtQwELaqXtoLUMrP8idX9AJSVomTOInUC2ypWiQ4ICr1giL_qla3zorsHtgTj8Ar9Bn6Hn0InoQZJ9lSQEhwiBRL4_zYY8839vgbQnbBBjClYxHpNOdRxmwcVbbMoxxsW5xZmTCJSwPv3vPD4-ztSX6yRvaGszAdP8RqwQ1HRpivcYAL2f40yJXUepyk4N7BBIzBWoiIPqy4o7IsD4lVAXEXYaOy5ybFMJ7rqjet0W8Q8yZiDSbn4Db5NHxsF2lyNl7M5Vgtf-Fx_N-_uUNu9ViUvuqUZ4usGX-XbEyGFHDb5OLIt-i8U-fnDQWoSNuQNgdmSHpu8Mywa89pY-nstGnhcj6EgGlD0-9fv505DyaSXl1SXOyl0vglqIUTy2ZqqPCa9oVm5pBuGYwoCkNFPP2JEUzw2lMnHeYDovILlGjrpqC5dCBCN-09cnzw5uPkMOpzOkQqBcsXaZYVinMJXhNAK8vBM-eGqZQXygrFpBCxZlWm8jJRPE6ZtlxVNskEU4qVNknvk3XfePOQ0MLm0uYirkpuoN0AeNgS3K-k5LjbKIoReTH0ba16wnPMuzGtB8cHG70OjT4iz1eys47m449SO4OK1NATuLUivGkWbc0SjkuzFYtH5EGnO6vnwIxaIsnQiLwMGvCXF9ST1_v74e7Rvwg_JpuA46ouDvMJWZ9_XpingJXm8lkYEz8AN1cU4A
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NbtQwELagHMqF_58tf0ZwASmrxEmc5Ahbqi20PaBW6i3yr2p166zI7qF74hF4BZ6B9-AheBJmnGShgJDgECmW7Fixx55vxuNvCHkOOoApHYtIpzmPMmbjqLJlHuWg2-LMyoRJdA3sH_DpUfb2OD_uY3PwLkzHD7F2uOHKCPs1LnB0SP-0ypXUepykYN9dJlcwpXewqN6v2aOyLA-pVQFzF-GosmcnxUCeH20v6qPfQOZFzBqUzs71LrNqG7gKMdbkdLxcyLFa_cLk-N__c4Nc6-EofdXJz01yyfhbZHMyZIG7TT7v-hbtd-r8oqGAFmkbMufAJknPDF4bdu0ZbSydnzQtPM6HKDBtaPrt46dT50FL0q9fKPp7qTR-BZLhxKqZGSq8pn2hmTtkXAY9ipWhIV4AxSAm6PbESYcpgag8hxJt3QyElw5c6Ka9Q4523hxOplGf1iFSKSi_SLOsUJxLMJwAXVkOxjk3TKW8UFYoJoWINasylZeJ4nHKtOWqskkmmFKstEl6l2z4xpv7hBY2lzYXcVVyA-MG2MOWYIElJccDR1GMyIthcmvVc55j6o1ZPdg-OOh1GPQRebauO--YPv5Y6-kgIzXMBJ6uCG-aZVuzhKN3tmLxiNzrhGf9HdhUS-QZGpGXQQT-0kE9eb29Hd62_qXyE7I5Pdzfq_d2D949IFcB1lVdWOZDsrH4sDSPADot5OOwQL4DW9wY-w
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3bbtQwEB2VIgEvLbfCUi5G8AJSVomTOInEC-yyarlUCFGpLyjyVY26dVZk96H7xCfwC3xD_6MfwZcwdpKFAkKCh0ixNM7FHnvO2OMzAI_RBlCpQh6oOGVBQk0YFCZPgxRtW5gYEVHhlgbe7rGd_eTVQXqwBs_6szAtP8Rqwc2NDD9fuwE-U-anQS6FUsMoRvfuAlxMWJg7nR6_X5FHJUnqM6si5M78TmVHTurieH7UPW-OfsOY5yGrtzmTTfjYf20banI0XMzFUC5_IXL839-5ChsdGCXPW-25BmvaXofLoz4H3A34umsb572Tys5rgliRND5vDk6R5Fi7Q8NVc0xqQ2aHdYNXZX0MmNIk_vb5y1Fl0UaSs1PiVnuJ0HaJelHxZT3VhFtFukI9qxzfMlpRJ4wV3fFPF8KErz2sROUSAhFxgiXSVFNUXdIzoevmJuxPXn4Y7QRdUodAxmj6AkWTTDIm0G1CbGUYuuZMUxmzTBouqeA8VLRIZJpHkoUxVYbJwkQJp1LS3ETxFqzb2urbQDKTCpPysMiZxnZD5GFy9L-inLntRp4N4Enft6XsGM9d4o1p2Xs-rtFL3-gDeLSSnbU8H3-UetirSIk94fZWuNX1oilpxNzabEHDAdxqdWf1HJxSc8cyNICnXgP-8oJy9GI89nd3_kX4AVx6N56Ub3b3Xm_DFcR0RRuTeRfW558W-h7iprm474fHdy4yF7M
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Insight+into+the+selective+mechanism+of+phosphoinositide+3-kinase+%CE%B3+with+benzothiazole+and+thiazolopiperidine+%CE%B3-specific+inhibitors+by+in+silico+approaches&rft.jtitle=Chemical+biology+%26+drug+design&rft.au=Zhu%2C+Jingyu&rft.au=Li%2C+Kan&rft.au=Xu%2C+Lei&rft.au=Jin%2C+Jian&rft.date=2019-05-01&rft.issn=1747-0285&rft.eissn=1747-0285&rft.volume=93&rft.issue=5&rft.spage=818&rft_id=info:doi/10.1111%2Fcbdd.13469&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1747-0277&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1747-0277&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1747-0277&client=summon